IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer

doi:10.1158/0008-5472.CAN-17-3131

. 2018 Jun 15;78(12):3293-3305.

doi: 10.1158/0008-5472.CAN-17-3131. Epub 2018 Mar 23.

IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer

Weizhi He¹, Jinghua Wu¹, Juanjuan Shi¹, Yan-Miao Huo², Wentao Dai³, Jing Geng¹, Ping Lu¹, Min-Wei Yang², Yuan Fang⁴, Wei Wang⁴, Zhi-Gang Zhang⁵, Aida Habtezion⁶, Yong-Wei Sun⁷, Jing Xue⁸

Affiliations

¹ State Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
² Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
³ Shanghai Center for Bioinformation Technology & Shanghai Engineering Research Center of Pharmaceutical Translation, Shanghai, China.
⁴ Department of General Surgery & Research Institute of Pancreatic Disease, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
⁵ State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, China.
⁶ Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California. jingxue@sjtu.edu.cn syw0616@126.com aidah@stanford.edu.
⁷ Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. jingxue@sjtu.edu.cn syw0616@126.com aidah@stanford.edu.
⁸ State Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. jingxue@sjtu.edu.cn syw0616@126.com aidah@stanford.edu.

PMID: 29572224
DOI: 10.1158/0008-5472.CAN-17-3131

IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer

Weizhi He et al. Cancer Res. 2018.

. 2018 Jun 15;78(12):3293-3305.

doi: 10.1158/0008-5472.CAN-17-3131. Epub 2018 Mar 23.

Authors

Affiliations

¹ State Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
² Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
³ Shanghai Center for Bioinformation Technology & Shanghai Engineering Research Center of Pharmaceutical Translation, Shanghai, China.
⁴ Department of General Surgery & Research Institute of Pancreatic Disease, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
⁵ State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, China.
⁶ Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California. jingxue@sjtu.edu.cn syw0616@126.com aidah@stanford.edu.
⁷ Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. jingxue@sjtu.edu.cn syw0616@126.com aidah@stanford.edu.
⁸ State Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. jingxue@sjtu.edu.cn syw0616@126.com aidah@stanford.edu.

PMID: 29572224
DOI: 10.1158/0008-5472.CAN-17-3131

Abstract

Chronic inflammation is a feature of pancreatic cancer, but little is known about how immune cells or immune cell-related signals affect pancreatic cancer stemness and development. Our previous work showed that IL22/IL22RA1 plays a vital role in acute and chronic pancreatitis progression by mediating cross-talk between immune cells and acinar cells or stellate cells, respectively. Here, we find IL22RA1 is highly but heterogeneously expressed in pancreatic cancer cells, with high expression associated with poor prognosis of patients with pancreatic cancer. The IL22RA1^hi population from pancreatic cancer harbored higher stemness potential and tumorigenicity. Notably, IL22 promoted pancreatic cancer stemness via IL22RA1/STAT3 signaling, establishing the mechanism of regulation of cancer stemness by microenvironmental factors. Moreover, STAT3 was indispensable for the maintenance of IL22RA1^hi cells. Overall, these findings provide a therapeutic strategy for patients with PDAC with high expression of IL22RA1.Significance: IL22RA1/STAT3 signaling enhances stemness and tumorigenicity in pancreatic cancer. Cancer Res; 78(12); 3293-305. ©2018 AACR.

PubMed Disclaimer

Cited by

A novel danshensu derivative ameliorates experimental colitis by modulating NADPH oxidase 4-dependent NLRP3 inflammasome activation.
Pan LL, Ren Z, Liu Y, Zhao Y, Li H, Pan X, Fang X, Liang W, Wang Y, Yang J, Sun J. Pan LL, et al. J Cell Mol Med. 2020 Nov;24(22):12955-12969. doi: 10.1111/jcmm.15890. Epub 2020 Sep 17. J Cell Mol Med. 2020. PMID: 32945118 Free PMC article.
Extensive protein S-nitrosylation associated with human pancreatic ductal adenocarcinoma pathogenesis.
Tan C, Li Y, Huang X, Wei M, Huang Y, Tang Z, Huang H, Zhou W, Wang Y, Hu J. Tan C, et al. Cell Death Dis. 2019 Dec 4;10(12):914. doi: 10.1038/s41419-019-2144-6. Cell Death Dis. 2019. PMID: 31801946 Free PMC article.
Several genes involved in the JAK-STAT pathway may act as prognostic markers in pancreatic cancer identified by microarray data analysis.
Pang C, Gu Y, Ding Y, Ma C, Yv W, Wang Q, Meng B. Pang C, et al. Medicine (Baltimore). 2018 Dec;97(50):e13297. doi: 10.1097/MD.0000000000013297. Medicine (Baltimore). 2018. PMID: 30557977 Free PMC article.
Zic family member 5 promotes survival in human pancreatic cancer and cholangiocarcinoma cells.
Satow R, Aiga Y, Watanabe T, Ishizuka N, Yoneda A, Fukami K. Satow R, et al. Biochem Biophys Rep. 2022 Jun 2;31:101289. doi: 10.1016/j.bbrep.2022.101289. eCollection 2022 Sep. Biochem Biophys Rep. 2022. PMID: 35669984 Free PMC article.
MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period.
Arman T, Baron JA, Lynch KD, White LA, Aldan J, Clarke JD. Arman T, et al. Toxicology. 2021 Dec;464:153021. doi: 10.1016/j.tox.2021.153021. Epub 2021 Nov 2. Toxicology. 2021. PMID: 34740672 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer

Affiliations

IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous